Shopping Cart
- Remove All
- Your shopping cart is currently empty
CB07-Exatecan, an ADC drug-linker conjugate, is utilized in the synthesis of ADCs and has demonstrated effectiveness in inhibiting the growth of HER2-positive cancer cells when conjugated with trastuzumab. This compound is valuable in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | CB07-Exatecan, an ADC drug-linker conjugate, is utilized in the synthesis of ADCs and has demonstrated effectiveness in inhibiting the growth of HER2-positive cancer cells when conjugated with trastuzumab. This compound is valuable in cancer research [1]. |
Molecular Weight | 1472.56 |
Formula | C71H94FN11O22 |
Cas No. | 2879247-31-9 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.